Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study

Immunotherapy has become a cornerstone for the treatment of renal cell carcinoma. Nevertheless, some patients are resistant to immune checkpoint inhibitors. The possibility to identify patients who cannot benefit from immunotherapy is a relevant clinical challenge. We analyzed the association betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Ernesto, Boldrini, Luca, Maratta, Maria Grazia, Gatta, Roberto, Votta, Claudio, Tortora, Giampaolo, Schinzari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012916/
https://www.ncbi.nlm.nih.gov/pubmed/36723981
http://dx.doi.org/10.1080/21645515.2023.2172926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012916/
https://www.ncbi.nlm.nih.gov/pubmed/36723981
http://dx.doi.org/10.1080/21645515.2023.2172926

Ejemplares similares